Eko Health develops AI-powered digital stethoscopes and software to enhance the early detection and monitoring of heart and lung diseases.
Eko is listed on Rocketlist with 9 active roles. The company is categorized as AI-powered Medical Devices & Diagnostics in MedTech. Eko is at Series D+ stage, with a B2B and B2C business model, headquartered in Emeryville, United States. Eko was founded in 2013 and has 153 employees. Eko has raised $173M. Active roles are refreshed daily from public hiring sources.